NK cell activation and protection occur independently of natural killer T cells during Trypanosoma cruzi infection

International Immunology

Volumn 17, Issue 5, 2005, Pages 607-613

  Duthie, Malcolm S ^a   Kahn, Stuart J ^a  

^a INFECTIOUS DISEASE RESEARCH INSTITUTE   (United States)

Author keywords

Cellular activation; Cytotoxicity; Inflammation; NK cells; Parasitic protozoan

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL INTERACTION; CELL PROTECTION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOLYSIS; FEMALE; LIVER CELL; LYMPHOCYTE COUNT; LYMPHOCYTE FUNCTION; MOUSE; NATURAL KILLER CELL; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; NONHUMAN; PARASITE IMMUNITY; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE ACTIVATION; TRYPANOSOMA CRUZI; TRYPANOSOMIASIS;

ALANINE TRANSAMINASE; ANIMALS; CHAGAS DISEASE; KILLER CELLS, NATURAL; LIVER; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; SPLEEN; T-LYMPHOCYTE SUBSETS; TRYPANOSOMA CRUZI;

EID: 26444480330     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxh239     Document Type: Article

References (44)

1. Bendelac, A., Lantz, O., Quimby, M. E., Yewdell, J. W., Bennink, J. R. and Brutkiewicz, R. R. 1995. CD1 recognition by mouse NK1+ T lymphocytes. Science 268:863.
2. Smiley, S. T., Kaplan, M. H. and Grusby, M. J. 1997. Immunoglobulin E production in the absence of interleukin-4-secreting CD1-dependent cells. Science 275:977.
3. Lantz, O. and Bendelac, A. 1994. An invariant T cell receptor alpha chain is used by a unique subset of major histocompatibility complex class I-specific CD4+ and CD4-8- T cells in mice and humans. J. Exp. Med. 180:1097.
4. Cui, J., Shin, T., Kawano, T. et al. 1997. Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors. Science 278:1623.
5. Taniguchi, M. and Nakayama, T. 2000. Recognition and function of Valpha14 NKT cells. Semin. Immunol. 12:543.
6. Godfrey, D. I., Hammond, K. J., Poulton, L. D., Smyth, M. J. and Baxter, A. G. 2000. NKT cells: Facts, functions and fallacies. Immunol. Today 21:573.
7. Kronenberg, M. and Gapin, L. 2002. The unconventional lifestyle of NKT cells. Nat. Rev. Immunol. 2:557.
8. Hansen, D. S. and Schofield, L. 2004. Regulation of immunity and pathogenesis in infectious diseases by CD1d-restricted NKT cells. Int. J. Parasitol. 34:15.
9. Wilson, M. T., Singh, A. K. and Van Kaer, L. 2002. Immunotherapy with ligands of natural killer T cells. Trends Mol. Med. 8:225.
10. Hammond, K. J. and Godfrey, D. I. 2002. NKT cells: Potential targets for autoimmune disease therapy? Tissue Antigens 59:353.
11. Biron, C. A. and Brossay, L. 2001. NK cells and NKT cells in innate defense against viral infections. Curr. Opin. Immunol. 13:458.
12. Flodstrom, M., Shi, F. D., Sarvetnick, N. and Ljunggren, H. G. 2002. The natural killer cell - friend or foe in autoimmune disease? Scand. J. Immunol. 55:432.
13. Scalzo, A. A. 2002. Successful control of viruses by NK cells - a balance of opposing forces? Trends Microbiol. 10:470.
14. Carnaud, C., Lee, D., Donnars, O. et al. 1999. Cutting edge: cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells. J. Immunol. 163:4647.
15. Eberl, G. and MacDonald, H. R. 2000. Selective induction of NK cell proliferation and cytotoxicity by activated NKT cells. Eur. J. Immunol. 30:985.
16. Smyth, M. J., Crowe, N. Y., Pellicci, D. G. et al. 2002. Sequential production of interferon-gamma by NK1.1(+) T cells and natural killer cells is essential for the antimetastatic effect of alpha-galactosylceramide. Blood 99:1259.
17. Matsuda, J. L., Gapin, L., Baron, J. L. et al. 2003. Mouse V alpha 14i natural killer T cells are resistant to cytokine polarization in vivo. Proc. Natl Acad. Sci. USA 100:8395.
18. WHO. 1991. Control of Chagas disease. In WHO Technical Report Series 811, p. 95. World Health Organization, Geneva.
19. Buckner, F. S. and Van Voorhis, W. C. 2000. Immune Response to Trypanosoma cruzi: Control of Infection and Pathogenesis of Chagas' Disease. Lippincott-Raven Press, Philadelphia.
20. Rottenberg, M., Cardoni, R. L., Andersson, R., Segura, E. L. and Orn, A. 1988. Role of T helper/inducer cells as well as natural killer cells in resistance to Trypanosoma cruzi infection. Scand. J. Immunol. 28:573.
21. Cardillo, F., Voltarelli, J. C., Reed, S. G. and Silva, J. S. 1996. Regulation of Trypanosoma cruzi infection in mice by gamma interferon and interleukin 10: Role of NK cells. Infect. Immun. 64:128.
22. Duthie, M. S., Wleklinski-Lee, M., Smith, S., Nakayama, T., Taniguchi, M. and Kahn, S. J. 2002. During Trypanosoma cruzi infection CD1d-restricted NK T cells limit parasitemia and augment the antibody response to a glycophosphoinositol-modified surface protein. Infect. Immun. 70:36.
23. Duthie, M. S., Kahn, M., White, M., Kapur, R. P. and Kahn, S. J. 2005. Critical proinflammatory and anti-inflammatory functions of different subsets of CD1d-restricted natural killer T cells during Trypanosoma cruzi infection. Infect. Immun., 73:181.
24. Plata, F., Garcia-Pons, F. and Eisen, H. 1984. Antigenic polymorphism of Trypanosoma cruzi: Clonal analysis of trypomastigote surface antigens. Eur. J. Immunol. 14:392.
25. Zingales, B., Pereira, M. E., Almeida, K. A. et al. 1997. Biological parameters and molecular markers of clone CL Brener - the reference organism of the Trypanosoma cruzi genome project. Mem. Inst. Oswaldo Cruz 92:811.
26. Hatcher, F. M., Kuhn, R. E., Cerrone, M. C. and Burton, R. C. 1981. Increased natural killer cell activity in experimental American trypanosomiasis. J. Immunol. 127:1126.
27. Antunez, M. I. and Cardoni, R. L. 2000. IL-12 and IFN-gamma production, and NK cell activity, in acute and chronic experimental Trypanosoma cruzi infections. Immunol. Lett. 71:103.
28. Ishikawa, H., Hisaeda, H., Taniguchi, M. et al. 2000. CD4(+) V(alpha)14 NKT cells play a crucial role in an early stage of protective immunity against infection with Leishmania major. Int. Immunol. 12:1267.
29. Smyth, M. J., Crowe, N. Y. and Godfrey, D. I. 2001. NK cells and NKT cells collaborate in host protection from methylcholanthrene-induced fibrosarcoma. Int. Immunol. 13:459.
30. Hayakawa, Y., Takeda, K., Yagita, H. et al. 2002. IFN-gamma-mediated inhibition of tumor angiogenesis by natural killer T -cell ligand, alpha-galactosylceramide. Blood 100:1728.
31. Kaneko, B. Y., Harada, M., Kawano, T. et al. 2000. Augmentation of Valpha14 NKT cell-mediated cytotoxicity by interleukin 4 in an autocrine mechanism resulting in the development of concanavalin A-induced hepatitis. J. Exp. Med. 191:105.
32. Takeda, K., Hayakawa, Y., Van Kaer, L., Matsuda, H., Yagita, H. and Okumura, K. 2000. Critical contribution of liver natural killer T cells to a murine model of hepatitis. Proc. Natl Acad. Sci. USA 97:5498.
33. Osman, Y., Kawamura, T., Naito, T. et al. 2000. Activation of hepatic NKT cells and subsequent liver injury following administration of alpha-galactosylceramide. Eur. J. Immunol. 30:1919.
34. Kawano, T., Cui, J., Koezuka, Y. et al. 1997. CD1d-restricted and TCR-mediated activation of Valpha14 NKT cells by glycosylceramides. Science 278:1626.
35. Taniguchi, M., Harada, M., Kojo, S., Nakayama, T. and Wakao, H. 2003. The regulatory role of Valpha14 NKT cells in innate and acquired immune response. Annu. Rev. Immunol. 21:483.
36. Brigl, M. and Brenner, M. B. 2004. CD1: Antigen presentation and T cell function. Annu. Rev. Immunol. 22:817.
37. van Dommelen, S. L., Tabarias, H. A., Smyth, M. J. and Degli-Esposti, M. A. 2003. Activation of natural killer (NK) T cells during murine cytomegalovirus infection enhances the antiviral response mediated by NK cells. J. Virol. 77:1877.
38. Gonzalez-Aseguinolaza, G., de Oliveira, C., Tomaska, M. et al. 2000. Alpha-galactosylceramide-activated Valpha 14 natural killer T cells mediate protection against murine malaria. Proc. Natl Acad. Sci. USA 97:8461.
39. Kawakami, K., Kinjo, Y., Yara, S. et al. 2001. Activation of Valpha14(+) natural killer T cells by alpha-galactosylceramide results in development of Th1 response and local host resistance in mice infected with Cryptococcus neoformans. Infect. Immun. 69:213.
40. Smyth, M. J., Thia, K. Y., Street, S. E. et al. 2000. Differential tumor surveillance by natural killer (NK) and NKT cells. J. Exp. Med. 191:661.
41. Trobonjaca, Z., Leithauser, F., Moller, P., Schirmbeck, R. and Reimann, J. 2001. Activating immunity in the liver. I. Liver dendritic cells (but not hepatocytes) are potent activators of ifn-gamma release by liver nkt cells. J. Immunol. 167:1413.
42. Holscher, C., Mohrs, M., Dai, W. J. et al. 2000. Tumor necrosis factor alpha-mediated toxic shock in Trypanosoma cruzi-infected interleukin 10-deficient mice. Infect. Immun. 68:4075.
43. Ben Younes-Chennoufi, A., Hontebeyrie-Joskowicz, M., Tricottet, V., Eisen, H., Reynes, M. and Said, G. 1988. Persistence of Trypanosoma cruzi antigens in the inflammatory lesions of chronically infected mice. Trans. R. Soc. Trop. Med. Hyg. 82:77.
44. Nunes, M. P., Sobral, A. C. and Coutinho, S. G. 1992. Quantification of Trypanosoma cruzi in the heart, lymph nodes and liver of experimentally infected mice, using limiting dilution analysis. Mem. Inst. Oswaldo Cruz 87:503.